Literature DB >> 2505417

Comparison between stool examination, serology and large bowel biopsy in diagnosing Schistosoma mansoni.

M I Yasawy, A R El Shiekh Mohamed, M A Al Karawi.   

Abstract

This report evaluates the diagnostic method in 167 patients with colonic schistosomiasis. These patients formed a part of a large number of patients who had sigmoidoscopy or colonoscopy for various gastrointestinal problems. During sigmoidoscopy or colonoscopy examination, typical intestinal Schistosomia lesions could be seen and at the same time several biopsies could be taken. Stool examination showed Schistosoma mansoni ova in only 19 patients (11.37%) of the 167 patients whose colonic biopsies were positive for Schistosoma mansoni. Serological tests were carried out in 115 of these patients and 88 patients (52.69%) had a titre of 64 or more. This study shows that endoscopic colonic biopsy is a better method than stool examination and serological tests in the diagnosis of intestinal or hepatosplenic schistosomiasis.

Entities:  

Mesh:

Year:  1989        PMID: 2505417     DOI: 10.1177/004947558901900313

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  3 in total

1.  A case of bowel schistosomiasis not adhering to endoscopic findings.

Authors:  Manfredi Rizzo; Pasquale Mansueto; Daniela Cabibi; Elisabetta Barresi; Kaspar Berneis; Mario Affronti; Gabriele Di Lorenzo; Sergio Vigneri; Giovam Battista Rini
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Schistosomiasis--An unusual cause of abdominal pseudotumor.

Authors:  Akintayo Oguntona Segun; Christopher Olutayo Alebiosu; A O J Agboola; A A F Banjo
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

3.  Chronic schistosomiasis in African immigrants in Israel: Lessons for the non-endemic setting.

Authors:  Yael Paran; Ronen Ben-Ami; Boris Orlev; Ora Halutz; Ofir Elalouf; Asaf Wasserman; Ofer Zimmerman; Ido Nahmani; Liane Rabinowich; Talya Finn
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.